[CLDX] QoQ Quarter Result on 31-Dec-2016 [#Q4]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
14-Mar-2017
Financial Year
2016
Quarter
31-Dec-2016 [#Q4]
Profit Trend
QoQ- -9.15%
YoY- 1.15%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
Revenue 3,924 3,829 1,534 1,874 2,220 1,389 1,303 108.40%
PBT -31,563 -28,566 -34,261 -32,307 -29,598 -31,952 -34,673 -6.06%
Tax -5,200 1,276 5,098 -5,090 -790 -828 -2,062 85.16%
NP -26,363 -28,566 -34,261 -32,307 -29,598 -31,952 -34,673 -16.68%
Tax Rate - - - - - - - -
Total Cost 30,287 32,395 35,795 34,181 31,818 33,341 35,976 -10.83%
Ratio Analysis
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
NP Margin -671.84 -746.04 -2,233.44 -1,723.96 -1,333.24 -2,300.36 -2,661.01 -60.01%
Per Share
30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 31/03/16 CAGR
EPS -3.05 -3.42 -4.19 -4.49 -4.41 -4.85 -5.27 -30.52%
EPS Diluted -3.05 -3.42 -4.19 -4.49 -4.41 -4.85 -5.27 -30.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.